[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE234850T1 - Phenylglyoxamide als spla2-inhibitoren - Google Patents

Phenylglyoxamide als spla2-inhibitoren

Info

Publication number
ATE234850T1
ATE234850T1 AT97948480T AT97948480T ATE234850T1 AT E234850 T1 ATE234850 T1 AT E234850T1 AT 97948480 T AT97948480 T AT 97948480T AT 97948480 T AT97948480 T AT 97948480T AT E234850 T1 ATE234850 T1 AT E234850T1
Authority
AT
Austria
Prior art keywords
phenylglyoxamides
spla2 inhibitors
spla2
inhibitors
class
Prior art date
Application number
AT97948480T
Other languages
English (en)
Inventor
Theodore Goodson Jr
Richard W Harper
David K Herron
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE234850T1 publication Critical patent/ATE234850T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808Acyclic saturated acids which can have further substituents on alkyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/70Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/72Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms
    • C07C235/76Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C07C235/78Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton the carbon skeleton containing rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Fats And Perfumes (AREA)
AT97948480T 1996-12-03 1997-11-25 Phenylglyoxamide als spla2-inhibitoren ATE234850T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3250996P 1996-12-03 1996-12-03
PCT/US1997/021434 WO1998024794A1 (en) 1996-12-03 1997-11-25 PHENYL GLYOXAMIDES AS sPLA2 INHIBITORS

Publications (1)

Publication Number Publication Date
ATE234850T1 true ATE234850T1 (de) 2003-04-15

Family

ID=21865305

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97948480T ATE234850T1 (de) 1996-12-03 1997-11-25 Phenylglyoxamide als spla2-inhibitoren

Country Status (13)

Country Link
US (1) US5916922A (de)
EP (1) EP0944636B1 (de)
JP (1) JP2001505882A (de)
KR (1) KR20000069249A (de)
AT (1) ATE234850T1 (de)
AU (1) AU5454498A (de)
BR (1) BR9713562A (de)
CA (1) CA2274019A1 (de)
DE (1) DE69720034T2 (de)
ES (1) ES2195182T3 (de)
HU (1) HUP9904218A2 (de)
IL (1) IL130201A0 (de)
WO (1) WO1998024794A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1066290A1 (de) 1998-03-31 2001-01-10 Shionogi & Co., Ltd. Pyrrolo[1,2-a]pyrazine spla2 inhibitoren
EP1085021A4 (de) 1998-05-21 2003-01-08 Shionogi & Co PYRROLO[1,2-B]PYRIDAZIN-DERIVATE MIT sPLA 2? HEMMENDEM EFFEKT
EP1091738B1 (de) 1998-06-30 2006-12-06 Eli Lilly And Company BICYCLISCHE sPLA 2-INHIBITOREN
AU6004799A (en) 1998-10-14 2000-05-01 Shionogi & Co., Ltd. Remedies or preventives for ischemic reflow failure
JP4636521B2 (ja) 1999-07-19 2011-02-23 塩野義製薬株式会社 sPLA2阻害作用を有する三環系化合物
US6673781B1 (en) 1999-08-02 2004-01-06 Shionogi & Co., Ltd. Tricyclic compounds having sPLA2-inhibitory activities
AU2001267825A1 (en) 2000-06-29 2002-01-08 Shionogi And Co., Ltd. Remedies for cirrhosis
JPWO2002000621A1 (ja) 2000-06-29 2004-04-22 塩野義製薬株式会社 X型sPLA2阻害作用を有する化合物
TWI314457B (de) 2001-03-19 2009-09-11 Shionogi & Co
CN102413825A (zh) 2009-04-29 2012-04-11 阿马里纳股份公司 含有epa和心血管剂的药物组合物以及使用其的方法
CN102631449B (zh) * 2012-05-18 2013-09-11 崔新明 一种治疗急性胰腺炎的中药组合物
IT201800003040A1 (it) * 2018-02-26 2019-08-26 Univ Pisa Nuovi attivatori dell’enzima SIRT1 per il trattamento delle patologie cardiovascolari e cardiometaboliche
CN110845345B (zh) * 2019-11-26 2021-11-09 中国科学院长春应用化学研究所 一种芳香型二胺单体及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2708184C3 (de) * 1977-02-25 1980-02-07 Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessler, 6000 Frankfurt Verfahren zur Herstellung von a -Ketocarbonsäureamide!! (A)
DE2733181B2 (de) * 1977-07-22 1979-08-30 Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessler, 6000 Frankfurt Verfahren zur Herstellung von N-substituierten a -Ketocarbonsäureamiden
RU2059603C1 (ru) * 1991-05-09 1996-05-10 Хоффманн-Ля Рош АГ ПРОИЗВОДНЫЕ α -ЗАМЕЩЕННЫХ АРИЛУКСУСНЫХ КИСЛОТ И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ
US5352690A (en) * 1992-07-01 1994-10-04 Eli Lilly And Company 1,2,4-trioxygenated benzene derivatives useful as leukotriene antagonists
ES2159347T3 (es) * 1995-12-13 2001-10-01 Lilly Co Eli Naftil-acetamidas como inhibidores de spla2.

Also Published As

Publication number Publication date
BR9713562A (pt) 2001-06-19
HUP9904218A2 (hu) 2000-05-28
KR20000069249A (ko) 2000-11-25
DE69720034T2 (de) 2003-12-04
US5916922A (en) 1999-06-29
EP0944636B1 (de) 2003-03-19
AU5454498A (en) 1998-06-29
EP0944636A4 (de) 2000-07-12
IL130201A0 (en) 2000-06-01
DE69720034D1 (de) 2003-04-24
EP0944636A1 (de) 1999-09-29
ES2195182T3 (es) 2003-12-01
JP2001505882A (ja) 2001-05-08
WO1998024794A1 (en) 1998-06-11
CA2274019A1 (en) 1998-06-11

Similar Documents

Publication Publication Date Title
MY112897A (en) Ih-indole-3-glyoxylamide spla2 inhibitors
ATE246501T1 (de) Pyrrole als spla2 inhibitoren
BR9508298A (pt) Inibidores de indolizina de spla2
ATE234850T1 (de) Phenylglyoxamide als spla2-inhibitoren
ATE203744T1 (de) Naphthyl-acetamide als spla2-inhibitoren
ATE326963T1 (de) Indolverbindungen als spla2 inhibitoren
ATE350367T1 (de) Spla2 inhibitoren
DE69910432D1 (de) Substituierte pyrroloindole
AU7053700A (en) Novel spla2 inhibitors
DE60126831D1 (de) Benz(g)indole und deren verwendung als spla2 inhibitoren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties